TORONTO, Nov. 26, 2020 /CNW/ - Dan
Legault, CEO, Antibe Therapeutics Inc. (TSX: ATE), shares
his company's story in an interview with TMX
Group.
The C-Suite at The Open video interview series highlights the
unique perspectives of listed companies on Toronto Stock Exchange
and TSX Venture Exchange. Videos provide insight into how
company executives think in the current business environment.
To see the latest C-Suite at The Open videos visit
https://www.tmxmoney.com/en/csuite.html.
About Antibe Therapeutics Inc. (TSX: ATE)
Antibe Therapeutics Inc. develops safer, non-addictive medicines
for pain and inflammation. Its technology involves linking a
hydrogen sulfide-releasing molecule to an existing drug to produce
an improved and patented medicine. The company's drug, ATB-346,
targets the global need for a safer, non-addictive drug for chronic
pain and inflammation. ATB-352, the second drug in pipeline,
targets the urgent global need for a non-addictive analgesic for
treating severe acute pain, while ATB-340 is a GI-safe derivative
of aspirin. Its operating segment includes Antibe and Citagenix.
The company generates maximum revenue from Citagenix segment and
geographically from Canada.
Citagenix segment is a marketer and distributor of regenerative
medicines serving the dental and orthopaedic market places. For
more information visit: http://www.antibethera.com/
About TMX Group (TSX: X)
TMX Group's key subsidiaries operate cash and derivative markets
and clearinghouses for multiple asset classes including equities
and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX
Alpha Exchange, The Canadian Depository for Securities, Montréal
Exchange, Canadian Derivatives Clearing Corporation,
Trayport and other TMX Group companies provide listing
markets, trading markets, clearing facilities, depository services,
technology solutions, data products and other services to the
global financial community. TMX Group is headquartered in
Toronto and operates offices
across North America (Montréal,
Calgary, Vancouver and New
York), as well as in key international markets including
London, Beijing and Singapore. For more information about TMX
Group, visit our website at www.tmx.com. Follow TMX Group on
Twitter: @TMXGroup.
SOURCE TMX Group Limited